Published in Circ Cardiovasc Imaging on May 09, 2011
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging (2012) 1.40
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging (2012) 1.28
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter. Eur J Nucl Med Mol Imaging (2013) 0.87
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res (2014) 0.85
Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging (2013) 0.82
New horizons in cardiac innervation imaging: introduction of novel (18)F-labeled PET tracers. Eur J Nucl Med Mol Imaging (2017) 0.79
PET imaging in heart failure: the role of new tracers. Heart Fail Rev (2017) 0.77
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG. Nucl Med Biol (2015) 0.76
PET imaging of the autonomic myocardial function: methods and interpretation. Clin Transl Imaging (2015) 0.75
Assessing the activity of cardiac sympathetic innervation with a novel PET tracer. Eur J Nucl Med Mol Imaging (2012) 0.75
Radionuclide imaging of neurohormonal system of the heart. Theranostics (2015) 0.75
Cardiac autonomic innervation. J Nucl Cardiol (2016) 0.75
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98
Light-induced expression of a MYB gene regulates anthocyanin biosynthesis in red apples. Plant Physiol (2006) 2.62
White grapes arose through the mutation of two similar and adjacent regulatory genes. Plant J (2007) 2.56
Proanthocyanidin synthesis and expression of genes encoding leucoanthocyanidin reductase and anthocyanidin reductase in developing grape berries and grapevine leaves. Plant Physiol (2005) 2.35
Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens (2003) 2.35
The grapevine transcription factor VvMYBPA1 regulates proanthocyanidin synthesis during fruit development. Plant Physiol (2007) 2.33
BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol (2004) 2.21
Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. Radiology (2010) 2.02
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation (2005) 1.82
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell (2012) 1.81
The transcription factor VvMYB5b contributes to the regulation of anthocyanin and proanthocyanidin biosynthesis in developing grape berries. Plant Physiol (2008) 1.78
The grapevine R2R3-MYB transcription factor VvMYBF1 regulates flavonol synthesis in developing grape berries. Plant Physiol (2009) 1.68
Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat (2010) 1.67
Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats. Circ Cardiovasc Imaging (2009) 1.64
Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. Circulation (2004) 1.57
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro. Microvasc Res (2005) 1.52
BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol (2007) 1.49
Identification of the flavonoid hydroxylases from grapevine and their regulation during fruit development. Plant Physiol (2005) 1.45
Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol (2007) 1.44
Effects of food intake and anesthetic on cardiac imaging and uptake of BMS747158-02 in comparison with FDG. J Nucl Cardiol (2009) 1.41
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging (2012) 1.40
Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation (2008) 1.37
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother Radiopharm (2003) 1.29
Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol (2008) 1.29
Ophthalmological aspects of Pierson syndrome. Am J Ophthalmol (2008) 1.27
Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med (2008) 1.26
Elastin-based molecular MRI of liver fibrosis. Hepatology (2013) 1.21
Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med (2011) 1.18
Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol (2012) 1.16
Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol (2003) 1.15
Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. PLoS One (2013) 1.15
Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. J Magn Reson Imaging (2004) 1.13
90Y and 111In complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent. Bioconjug Chem (2004) 1.13
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med (2011) 1.13
Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma. Melanoma Res (2010) 1.08
Renal effects of glucagon-like peptide in rats. Eur J Pharmacol (2002) 1.06
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Mol Cancer Ther (2011) 1.05
Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J Nucl Med (2009) 1.04
CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs. Clin Cancer Res (2012) 1.04
Two new grape cultivars, bud sports of Cabernet Sauvignon bearing pale-coloured berries, are the result of deletion of two regulatory genes of the berry colour locus. Plant Mol Biol (2006) 1.03
Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation. J Nucl Med (2011) 1.03
Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas. Oncology (2003) 1.03
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma. Radiology (2012) 1.02
Preclinical evaluation of imaging biomarkers for prostate cancer bone metastasis and response to cabozantinib. J Natl Cancer Inst (2014) 1.01
Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol (2004) 1.01
Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo. J Nucl Med (2010) 0.99
Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing. Magn Reson Med (2010) 0.99
Robust estimation of the apparent diffusion coefficient (ADC) in heterogeneous solid tumors. Magn Reson Med (2009) 0.99
Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity. Magn Reson Med (2009) 0.98
Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg (2008) 0.97
Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. Int J Cancer (2011) 0.95
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents. Bioconjug Chem (2006) 0.95
Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res (2003) 0.94
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting. J Nucl Med (2005) 0.94
Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126. Microvasc Res (2006) 0.93
Bayesian estimation of changes in transverse relaxation rates. Magn Reson Med (2010) 0.92
Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment. PLoS One (2013) 0.91
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ Cardiovasc Imaging (2011) 0.91
Recall of drug utilization depends on subtle structural questionnaire characteristics. Pharm World Sci (2007) 0.91
DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics (2007) 0.91
Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model. Neoplasia (2004) 0.91
The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy. Neoplasia (2006) 0.91
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. J Pathol (2011) 0.90
Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch (2009) 0.89
Noninvasive detection of carboxypeptidase G2 activity in vivo. NMR Biomed (2010) 0.88
Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging. Magn Reson Med (2011) 0.87
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors. Bioorg Med Chem Lett (2008) 0.87
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol (2006) 0.87
The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease. Semin Nucl Med (2011) 0.87
Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits. J Nucl Cardiol (2010) 0.86